- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Acquired Pure Red Cell Aplasia
Total 3978 results
-
Beth FaimanNational Cancer Institute (NCI)TerminatedGlutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving BortezomibMultiple Myeloma | Peripheral Neuropathy | Chemotherapeutic Agent ToxicityUnited States
-
Cleave Biosciences, Inc.TerminatedLymphoid Hematological Malignancies | Relapsed and Refractory Multiple MyelomaCanada, United States
-
University Health Network, TorontoCompletedMultiple Myeloma | Renal FailureCanada
-
Masonic Cancer Center, University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI)TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Vaishali SanchorawalaCelgene CorporationCompletedMultiple MyelomaUnited States
-
Boston Medical CenterCompletedMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Massachusetts General HospitalDana-Farber Cancer InstituteCompletedLymphoma | Leukemia | Multiple Myeloma | Myelodysplastic SyndromeUnited States
-
New Mexico Cancer Care AllianceNovartisTerminatedMultiple Myeloma in RelapseUnited States
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, South Africa
-
Genzyme, a Sanofi CompanyNo longer availableMultiple Myeloma | Non-Hodgkin's Lymphoma | Hodgkin's Disease
-
NYU Langone HealthUnicorn Pacific CorporationTerminatedMyelomaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedMultiple Myeloma | MucositisUnited States
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage III Multiple Myeloma | Unspecified Adult Solid Tumor, Protocol Specific | Refractory Multiple MyelomaUnited States
-
Otsuka Beijing Research InstituteOtsuka Pharmaceutical Co., Ltd.UnknownNon-Hodgkin's Lymphoma(NHL) | Multiple Myeloma(MM)Hong Kong
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Non-Hodgkin Lymphoma | Relapsed or Refractory Chronic Lymphocytic LeukemiaUnited Kingdom, Spain, France, Australia
-
National Cancer Institute (NCI)TerminatedNodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedHIV Infection | Unspecified Childhood Solid Tumor, Protocol Specific | Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal... and other conditionsUnited States
-
Ontario Clinical Oncology Group (OCOG)PfizerNot yet recruitingRefractory Multiple MyelomaCanada
-
Jules Bordet InstituteRayzeBio, Inc.Not yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory | Multiple Myeloma ProgressionBelgium
-
Nantes University HospitalJanssen PharmaceuticaNot yet recruiting
-
Centro di Riferimento Oncologico - AvianoRecruiting
-
FengYan JinNot yet recruitingMultiple Myeloma | Minimal Residual Disease
-
Carl Ola Landgren, MD, PhDJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple Myeloma | OsteoporosisUnited States
-
Massachusetts General HospitalConquer Cancer FoundationRecruitingLymphoma | Leukemia | Multiple Myeloma | Hematologic Malignancy | Blood CancerUnited States
-
Fu chengcheng PhDNot yet recruitingMultiple Myeloma at First Relapse
-
Institute of Hematology & Blood Diseases HospitalShanghai Kuaixu Biotechnology Co., LtdRecruitingMultiple MyelomaChina
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMultiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Cryoglobulinemic Vasculitis
-
University of Alabama at BirminghamRecruitingMultiple MyelomaUnited States
-
Polish Myeloma ConsortiumJanssen-Cilag Ltd.; Bioscience, S.A.Recruiting
-
Harpoon TherapeuticsActive, not recruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma of BoneUnited States, France, Spain
-
Janssen Research & Development, LLCActive, not recruiting
-
University of Michigan Rogel Cancer CenterJanssen Scientific Affairs, LLCActive, not recruiting
-
International Myeloma FoundationJanssen Scientific Affairs, LLC; Celgene; Amgen; Trevie, Inc.Active, not recruitingSmoldering Multiple MyelomaUnited States
-
Intergroupe Francophone du MyelomeBristol-Myers Squibb; Sanofi; AmgenActive, not recruiting
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedLymphoma | Multiple Myeloma | Solid Tumor | Malignant Neoplasm | Mutation AbnormalityUnited States
-
Memorial Sloan Kettering Cancer CenterPatient-Centered Outcomes Research Institute; Hackensack Meridian HealthActive, not recruitingMultiple Myeloma | Hodgkin Disease | Non-Hodgkin LymphomaUnited States
-
AstraZenecaTerminatedLymphoma | Multiple Myeloma | Advanced Solid Tumors | Hematologic MalignanciesUnited States
-
Assistance Publique - Hôpitaux de ParisActive, not recruiting
-
Abramson Cancer Center of the University of PennsylvaniaCompleteda Diagnosis of MGUS or SMM by IMWG CriteriaUnited States
-
The Cleveland ClinicCompletedAmyloidosis | Spinal Stenosis | Amyloid | Transthyretin Amyloidosis | Primary Amyloidosis of Light Chain TypeUnited States
-
University of Illinois at ChicagoCompletedMultiple Myeloma, Relapsed | Multiple Myeloma, Refractory to Standard TreatmentUnited States
-
GPCR Therapeutics, Inc.CompletedMultiple Myeloma | Hodgkin Disease | Non-Hodgkin LymphomaUnited States
-
University of ChicagoCompletedLymphoma | Leukemia | Multiple Myeloma | Myelodysplastic SyndromeUnited States
-
Institut Cancerologie de l'OuestTerminatedMultiple Myeloma in RelapseFrance